December 24, 2013
The Danish-based LEO Pharma A/S, its Japanese subsidiary LEO Pharma K.K. and Kyowa Hakko Kirin announced on December 20 that the three companies entered into a distribution and copromotion agreement on December 19 for the fixed-dose combination topical treatment containing...read more